150 related articles for article (PubMed ID: 2409720)
1. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
[TBL] [Abstract][Full Text] [Related]
2. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
[TBL] [Abstract][Full Text] [Related]
3. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
4. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
Roe EA; Jones RJ
Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
[TBL] [Abstract][Full Text] [Related]
5. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
Lieberman MM; Walker HL; Ayala E; Chapa I
J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas immunoglobulin and vaccine in burn patients.
Bose B
Lancet; 1981 Feb; 1(8217):435. PubMed ID: 6110056
[No Abstract] [Full Text] [Related]
7. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
Minukhin VV; Tsyganenko AIa
Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
[TBL] [Abstract][Full Text] [Related]
8. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
Minukhin VV; Tsyganenko VIa
Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
[TBL] [Abstract][Full Text] [Related]
9. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
10. [Immunoprophylaxis and immunotherapy of experimental Pseudomonas aeruginosa sepsis].
Grishina IA; Terekhova RP; Marchuk AI
Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):14-7. PubMed ID: 3087118
[TBL] [Abstract][Full Text] [Related]
11. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM
Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
[TBL] [Abstract][Full Text] [Related]
12. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
Jones RJ; Roe EA; Gupta JL
Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445
[TBL] [Abstract][Full Text] [Related]
13. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection.
Montie TC; Drake D; Sellin H; Slater O; Edmonds S
Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785
[No Abstract] [Full Text] [Related]
14. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
[TBL] [Abstract][Full Text] [Related]
15. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi.
Roe EA; Jones RJ
Rev Infect Dis; 1983; 5 Suppl 5():S922-30. PubMed ID: 6419315
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine.
Jones RJ
J Hyg (Lond); 1979 Jun; 82(3):453-62. PubMed ID: 109501
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
Cryz SJ; Fürer E; Sadoff JC; Fredeking T; Que JU; Cross AS
J Infect Dis; 1991 May; 163(5):1055-61. PubMed ID: 1902245
[TBL] [Abstract][Full Text] [Related]
19. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
[No Abstract] [Full Text] [Related]
20. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
